5.2 listing of clinical sites and cvs pages 1 41

Pfizer Documents (PHMPT/FDA)

Pfizer Bla Submission

Pfizer 16 Plus Documents

41

Download PDF ↗ Live URL (may be dead)

Document text

FDA-CBER-2021-5683-0000013
FDA-CBER-2021-5683-0000014
FDA-CBER-2021-5683-0000015
FDA-CBER-2021-5683-0000016
FDA-CBER-2021-5683-0000017
FDA-CBER-2021-5683-0000018
FDA-CBER-2021-5683-0000019
FDA-CBER-2021-5683-0000020
FDA-CBER-2021-5683-0000021
FDA-CBER-2021-5683-0000022
FDA-CBER-2021-5683-0000023
FDA-CBER-2021-5683-0000024
FDA-CBER-2021-5683-0000025
FDA-CBER-2021-5683-0000026
FDA-CBER-2021-5683-0000027
FDA-CBER-2021-5683-0000028
FDA-CBER-2021-5683-0000029
FDA-CBER-2021-5683-0000030
FDA-CBER-2021-5683-0000031
FDA-CBER-2021-5683-0000032
FDA-CBER-2021-5683-0000033
FDA-CBER-2021-5683-0000034
FDA-CBER-2021-5683-0000035
FDA-CBER-2021-5683-0000036
FDA-CBER-2021-5683-0000037
FDA-CBER-2021-5683-0000038
FDA-CBER-2021-5683-0000039
FDA-CBER-2021-5683-0000040
FDA-CBER-2021-5683-0000041
FDA-CBER-2021-5683-0000042
FDA-CBER-2021-5683-0000043
FDA-CBER-2021-5683-0000044
FDA-CBER-2021-5683-0000045
FDA-CBER-2021-5683-0000046
FDA-CBER-2021-5683-0000047
FDA-CBER-2021-5683-0000048
FDA-CBER-2021-5683-0000049
FDA-CBER-2021-5683-0000050
FDA-CBER-2021-5683-0000051
FDA-CBER-2021-5683-0000052
FDA-CBER-2021-5683-0000053